Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients
AIDS Research and Human Retroviruses · 2024
DOI: 10.1089/aid.2023.0102 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, 2024. Verfasst von Farzaneh Ghassabi und 6 weiteren Autor:innen. Beteiligte Einrichtung: HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: HIV Envelope Protein gp41, HIV Infections, HIV-1, HIV Fusion Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Ava Hashempour
Zitieren
APA
Ghassabi, F., Hashempour, A., Dehghani, B., Hasanshahi, Z., Khodadad, N., Behizadeh, F., & Davarpanah, M. A. (2024). Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients. AIDS Research and Human Retroviruses. https://doi.org/10.1089/aid.2023.0102
Vancouver
Ghassabi F, Hashempour A, Dehghani B, Hasanshahi Z, Khodadad N, Behizadeh F, et al. Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients. AIDS Research and Human Retroviruses. 2024. doi:10.1089/aid.2023.0102
BibTeX
@article{Ghassabi2024,
author = {Ghassabi, Farzaneh and Hashempour, Ava and Dehghani, Behzad and Hasanshahi, Zahra and Khodadad, Nastaran and Behizadeh, Farideh and Davarpanah, Mohamad Ali},
title = {Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naïve HIV Patients},
journal = {AIDS Research and Human Retroviruses},
year = {2024},
doi = {10.1089/aid.2023.0102}
}
EUVIMED